These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 32418537)

  • 1. Clinical experience regarding safety and diagnostic value of cardiovascular magnetic resonance in patients with a subcutaneous implanted cardioverter/defibrillator (S-ICD) at 1.5 T.
    Holtstiege V; Meier C; Bietenbeck M; Chatzantonis G; Florian A; Köbe J; Reinke F; Eckardt L; Yilmaz A
    J Cardiovasc Magn Reson; 2020 May; 22(1):35. PubMed ID: 32418537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular Magnetic Resonance to Predict Appropriate Implantable Cardioverter Defibrillator Therapy in Ischemic and Nonischemic Cardiomyopathy Patients Using Late Gadolinium Enhancement Border Zone: Comparison of Four Analysis Methods.
    Jablonowski R; Chaudhry U; van der Pals J; Engblom H; Arheden H; Heiberg E; Wu KC; Borgquist R; Carlsson M
    Circ Cardiovasc Imaging; 2017 Sep; 10(9):. PubMed ID: 28838961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular magnetic resonance imaging in patients with cardiac implantable electronic devices: a device-dependent imaging strategy for improved image quality.
    Hilbert S; Jahnke C; Loebe S; Oebel S; Weber A; Spampinato R; Richter S; Doering M; Bollmann A; Sommer P; Hindricks G; Paetsch I
    Eur Heart J Cardiovasc Imaging; 2018 Sep; 19(9):1051-1061. PubMed ID: 29048460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes after primary prevention defibrillator implantation are better predicted when the left ventricular ejection fraction is assessed by cardiovascular magnetic resonance.
    Champ-Rigot L; Gay P; Seita F; Benouda L; Morello R; Pellissier A; Alexandre J; Saloux E; Milliez P
    J Cardiovasc Magn Reson; 2020 Jun; 22(1):48. PubMed ID: 32580786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality assessment of cardiac magnetic resonance myocardial scar imaging prior to ventricular arrhythmia ablation.
    Shah R; Sharma A; Assis F; De Vasconcellos HD; Alugubelli N; Pandey P; Akhtar T; Gasperetti A; Zhou S; Halperin H; Zimmerman SL; Tandri H; Kolandaivelu A
    Int J Cardiovasc Imaging; 2023 Feb; 39(2):411-421. PubMed ID: 36331683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing cardiac implantable electronic device-induced artefacts in cardiac magnetic resonance imaging.
    Vuorinen AM; Lehmonen L; Karvonen J; Holmström M; Kivistö S; Kaasalainen T
    Eur Radiol; 2023 Feb; 33(2):1229-1242. PubMed ID: 36029346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of fast multi-slice and standard segmented techniques for detection of late gadolinium enhancement in ischemic and non-ischemic cardiomyopathy - a prospective clinical cardiovascular magnetic resonance trial.
    Muehlberg F; Arnhold K; Fritschi S; Funk S; Prothmann M; Kermer J; Zange L; von Knobelsdorff-Brenkenhoff F; Schulz-Menger J
    J Cardiovasc Magn Reson; 2018 Feb; 20(1):13. PubMed ID: 29458430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical utility of cardiovascular magnetic resonance imaging in patients with implantable cardioverter defibrillators presenting with electrical instability or worsening heart failure symptoms.
    Lindemann F; Oebel S; Paetsch I; Arya A; Dagres N; Richter S; Dinov B; Hilbert S; Loebe S; Stegmann C; Doering M; Bollmann A; Hindricks G; Jahnke C
    J Cardiovasc Magn Reson; 2020 May; 22(1):32. PubMed ID: 32389126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of adenosine stress cardiovascular magnetic resonance perfusion imaging in patients with MR-conditional transvenous permanent pacemakers and defibrillators.
    Pavon AG; Porretta AP; Arangalage D; Domenichini G; Rutz T; Hugelshofer S; Pruvot E; Monney P; Pascale P; Schwitter J
    J Cardiovasc Magn Reson; 2022 Jan; 24(1):9. PubMed ID: 35022037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of cardiovascular magnetic resonance-derived circumferential strain parameters with the risk of ventricular arrhythmia and all-cause mortality in patients with prior myocardial infarction and primary prevention implantable cardioverter defibrillator.
    Paiman EHM; Androulakis AFA; Shahzad R; Tao Q; Zeppenfeld K; Lamb HJ; van der Geest RJ
    J Cardiovasc Magn Reson; 2019 May; 21(1):28. PubMed ID: 31096987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does stress perfusion imaging improve the diagnostic accuracy of late gadolinium enhanced cardiac magnetic resonance for establishing the etiology of heart failure?
    Gulsin GS; Shetye A; Khoo J; Swarbrick DJ; Levelt E; Lai FY; Squire IB; Arnold JR; McCann GP
    BMC Cardiovasc Disord; 2017 Apr; 17(1):98. PubMed ID: 28390413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Wideband Late Gadolinium Enhancement Cardiac Magnetic Resonance Imaging on Device-Related Artifacts in Different Implantable Cardioverter-Defibrillator Types.
    Singh A; Chen W; Patel HN; Alvi N; Kawaji K; Besser SA; Tung R; Zou J; Lang RM; Mor-Avi V; Patel AR
    J Magn Reson Imaging; 2021 Oct; 54(4):1257-1265. PubMed ID: 33742522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complexity of scar and ventricular arrhythmias in dilated cardiomyopathy of any etiology: Long-term data from the SCARFEAR (Cardiovascular Magnetic Resonance Predictors of Appropriate Implantable Cardioverter-Defibrillator Therapy Delivery) Registry.
    Pedretti S; Vargiu S; Baroni M; Dellegrottaglie S; Lanzarin B; Roghi A; Milazzo A; Quattrocchi G; Lunati M; Pedrotti P
    Clin Cardiol; 2018 Apr; 41(4):494-501. PubMed ID: 29663442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of cardiovascular magnetic resonance in patients with biopsy-proven systemic sarcoidosis.
    Flamée L; Symons R; Degtiarova G; Dresselaers T; Gheysens O; Wuyts W; Van Cleemput J; Bogaert J
    Eur Radiol; 2020 Jul; 30(7):3702-3710. PubMed ID: 32166494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular magnetic resonance risk stratification in patients with clinically suspected myocarditis.
    Schumm J; Greulich S; Wagner A; Grün S; Ong P; Bentz K; Klingel K; Kandolf R; Bruder O; Schneider S; Sechtem U; Mahrholdt H
    J Cardiovasc Magn Reson; 2014 Jan; 16(1):14. PubMed ID: 24461053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular magnetic resonance in patients with magnetic resonance conditional pacemaker systems at 1.5 T: influence of pacemaker related artifacts on image quality including first pass perfusion, aortic and mitral valve assessment, flow measurement, short tau inversion recovery and T1-weighted imaging.
    Klein-Wiele O; Garmer M; Busch M; Mateiescu S; Urbien R; Barbone G; Kara K; Schulte-Hermes M; Metz F; Hailer B; Grönemeyer D
    Int J Cardiovasc Imaging; 2017 Mar; 33(3):383-394. PubMed ID: 27815793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Image Quality of Cardiac Magnetic Resonance Imaging in Patients With an Implantable Cardioverter Defibrillator System Designed for the Magnetic Resonance Imaging Environment.
    Schwitter J; Gold MR; Al Fagih A; Lee S; Peterson M; Ciuffo A; Zhang Y; Kristiansen N; Kanal E; Sommer T;
    Circ Cardiovasc Imaging; 2016 May; 9(5):. PubMed ID: 27151268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis.
    Greulich S; Deluigi CC; Gloekler S; Wahl A; Zürn C; Kramer U; Nothnagel D; Bültel H; Schumm J; Grün S; Ong P; Wagner A; Schneider S; Nassenstein K; Gawaz M; Sechtem U; Bruder O; Mahrholdt H
    JACC Cardiovasc Imaging; 2013 Apr; 6(4):501-11. PubMed ID: 23498675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scar extent evaluated by late gadolinium enhancement CMR: a powerful predictor of long term appropriate ICD therapy in patients with coronary artery disease.
    Alexandre J; Saloux E; Dugué AE; Lebon A; Lemaitre A; Roule V; Labombarda F; Provost N; Gomes S; Scanu P; Milliez P
    J Cardiovasc Magn Reson; 2013 Jan; 15(1):12. PubMed ID: 23331500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy.
    Wu KC; Weiss RG; Thiemann DR; Kitagawa K; Schmidt A; Dalal D; Lai S; Bluemke DA; Gerstenblith G; Marbán E; Tomaselli GF; Lima JA
    J Am Coll Cardiol; 2008 Jun; 51(25):2414-21. PubMed ID: 18565399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.